When it Comes to Nonproliferation, China Has Been a ‘Free Rider’

When it Comes to Nonproliferation, China Has Been a ‘Free Rider’
Iraqi Foreign Minister Hoshyar Zebari and his Chinese counterpart Wang Yi speak during a press conference in Baghdad, Iraq, Feb. 23, 2014 (AP photo by Ahmed Saad).

When asked recently by New York Times columnist Thomas L. Friedman whether China, as the “biggest energy investor in Iraq,” should behave more like a stakeholder there, U.S. President Barack Obama had a pointed reply. The Chinese, he said, “have been free riders for the last 30 years and it’s worked really well for them,” while the United States has had to bear the burdens of maintaining international security and prosperity for the good of the world.

Those comments triggered a sharply negative reaction in the Chinese press. Although Obama might not have intended to be so blunt, his remarks reflect a widespread view within Washington that China, in order to minimize its foreign risks and costs, has not been as helpful as it should on a range of global challenges, especially nonproliferation.

China has benefited in many ways from decades-long U.S. efforts to stabilize Iraq. The wars have diverted U.S. attention and resources from Chinese actions in Asia, driven the U.S. government into deeper debt, alienated many countries from American foreign policy, and allowed Chinese analysts to learn too much about the capabilities and vulnerabilities of the U.S. military. While reaping those gains, Chinese policymakers skillfully managed to avoid antagonizing the U.S. over Iraq. Its opposition to U.S. actions there was more constrained than that of many other governments, including close U.S. allies like France and Germany.

Keep reading for free.

Register below for instant access to the rest of this article (no credit card required). You'll also get our free newsletters and two pieces of expert analysis each month. Simply click one of the icons below to instantly login with a social account, or use your email address:
Or skip to premium access for just $12 for the first 12 weeks.
After 12 weeks you'll be charged $77 annually.